HealthFinSMEsabout 1 hour ago
bit.bio Raises $25M Series D Funding
1 min read
Cambridge, UK-based human cell programming company bit.bio raised $25M in Series D funding on 04/11/2026. Backers included M&G Investments and Dr. Jonathan Milner. The company intends to use the funds to expand its portfolio of human cell types, increase market availability, and support wider customer access.
Level
Hype check
Tap to vote and see what everyone thinks.
